Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Evaluation of the Vitagen Extracorporeal Liver Assist Device (ELAD) System in the Management of the Patients With Fulminant Hepatic Failure

NCT00030225 is registered in ClinicalTrials.gov with Vital Therapies, Inc. as lead sponsor.

NCT NCT00030225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00030225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Evaluation of the Vitagen Extracorporeal Liver Assist Device (ELAD) System in the Management of the Patients With Fulminant Hepatic Failure
Lead sponsor
Vital Therapies, Inc.
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2002
Completion date
February 28, 2003
Enrollment
19 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

fulminant hepatic failure